AR043443A1 - Procedimiento de preparacion de tetrahidrotriazolopirazinas y productos intermedios - Google Patents

Procedimiento de preparacion de tetrahidrotriazolopirazinas y productos intermedios

Info

Publication number
AR043443A1
AR043443A1 ARP040100646A AR043443A1 AR 043443 A1 AR043443 A1 AR 043443A1 AR P040100646 A ARP040100646 A AR P040100646A AR 043443 A1 AR043443 A1 AR 043443A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
atoms
alkyl
compound
Prior art date
Application number
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AR043443A1 publication Critical patent/AR043443A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se proporciona un procedimiento para la preparación de 5,6,7,8-tetrahidro[1,2,4]-triazolo[4,3-a]pirazinas sustituidas que son útiles en la síntesis de inhibidores de la dipeptidil peptidasa-IV para el tratamiento de la diabetes tipo 2. También se proporcionan productos intermedios útiles obtenidos en el procedimiento. Reivindicación 1: Un procedimiento para preparar un compuesto de fórmula estructural (1) o una sal ácida del mismo, en la que R1 es fenilo opcionalmente sustituido o alquilo C1-4 insustituido o sustituido con uno a cinco átomos de F; y R2, R3, R4, y R5 son cada uno de forma independiente H, alquilo C1-4 o bencilo opcionalmente sustituido; o R2 y R3 tomados juntos con los átomos de C a los que están unidos forman un anillo alifático cíclico de 5 a 7 miembros, que comprende la etapa de ciclar un compuesto de fórmula estructural IV en un disolvente orgánico adecuado.
ARP040100646 2003-03-07 2004-03-01 Procedimiento de preparacion de tetrahidrotriazolopirazinas y productos intermedios AR043443A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45274803P 2003-03-07 2003-03-07

Publications (1)

Publication Number Publication Date
AR043443A1 true AR043443A1 (es) 2005-07-27

Family

ID=32990678

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100646 AR043443A1 (es) 2003-03-07 2004-03-01 Procedimiento de preparacion de tetrahidrotriazolopirazinas y productos intermedios

Country Status (3)

Country Link
AR (1) AR043443A1 (es)
TW (1) TW200500368A (es)
WO (1) WO2004080958A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012395A2 (en) 2004-07-23 2006-02-02 Susan Marie Royalty Peptidase inhibitors
PL1942898T5 (pl) 2005-09-14 2014-10-31 Takeda Pharmaceuticals Co Inhibitory peptydazy dipeptydylowej do leczenia cukrzycy
CN102675221A (zh) 2005-09-16 2012-09-19 武田药品工业株式会社 用于制备嘧啶二酮衍生物的方法中的中间体
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
ES2627688T3 (es) 2010-04-02 2017-07-31 Ogeda Sa Novedosos compuestos antagonistas selectivos del receptor de NK-3, composición farmacéutica y métodos para uso en trastornos mediados por los receptores de NK-3
US10065960B2 (en) 2010-04-02 2018-09-04 Ogeda Sa NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
CN102372716A (zh) 2010-08-09 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
CN101973997B (zh) * 2010-09-30 2012-06-06 浙江大学 一种磷酸西他列汀侧链的制备方法
CA2840814A1 (en) 2011-06-29 2013-01-03 Ranbaxy Laboratories Limited Solid dispersions of sitagliptin and processes for their preparation
US20150051213A1 (en) 2011-06-30 2015-02-19 Suresh Babu Jayachandra Novel salts of sitagliptin
CN103906750B9 (zh) 2011-10-03 2016-10-12 欧洲筛选有限公司 作为选择性NK-3受体拮抗剂的新型手性N-酰基-5,6,7,(8-取代的)-四氢-[1，2,4]三唑并[4，3-a]吡嗪、药物组合物、用于NK-3受体介导的疾病中的方法及其手性合成
EP2788352A1 (en) 2011-12-08 2014-10-15 Ranbaxy Laboratories Limited Amorphous form of sitagliptin salts
TR201902080T4 (tr) 2014-09-25 2019-03-21 Ogeda Sa N-asil-(3-sübstitüe)-(8-sübstitüe)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinlerinin yeni kiral sentezleri.
EP3159343B1 (en) 2015-10-22 2017-07-19 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of triazole and salt thereof
US10047094B1 (en) 2017-02-10 2018-08-14 F.I.S.—Fabbrica Italiana Sintetici S.p.A. Process for the preparation of triazole and salt thereof
EP3424927B1 (en) 2017-07-04 2019-04-17 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Efficient process for the preparation of sitagliptin through a very effective preparation of the intermediate 2,4,5-trifluorophenylacetic acid
WO2019137358A1 (zh) * 2018-01-09 2019-07-18 江苏恒瑞医药股份有限公司 一种parp抑制剂及其中间体的制备方法
ES2770143T3 (es) 2018-02-13 2020-06-30 Fis Fabbrica Italiana Sintetici Spa Nuevo procedimiento eficiente para la preparación de sitagliptina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3252483B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 ３環性トリアゾロ誘導体の製造方法
UA74912C2 (en) * 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
MY139563A (en) * 2002-09-04 2009-10-30 Bristol Myers Squibb Co Heterocyclic aromatic compounds useful as growth hormone secretagogues

Also Published As

Publication number Publication date
TW200500368A (en) 2005-01-01
WO2004080958A2 (en) 2004-09-23
WO2004080958A3 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
AR043443A1 (es) Procedimiento de preparacion de tetrahidrotriazolopirazinas y productos intermedios
ES2592515T3 (es) Inhibidores de CDK
PE20120172A1 (es) Compuestos heterociclicos fusionados que contiene nitrogeno como inhibidores de la produccion de beta-amiloide
AR049374A1 (es) Sintesis de compuestos de ester y acido borico
AR038419A1 (es) Derivados de piridina y quinolina
Martínez‐Estibalez et al. Strategies Based on Aryllithium and N‐Acyliminium Ion Cyclizations for the Stereocontrolled Synthesis of Alkaloids and Related Systems
PE20091056A1 (es) PIRIDO[3,2-e]PIRAZINAS, SU PROCEDIMIENTO DE PREPARACION Y USO COMO INHIBIDORES DE FOSFODIESTERASA 10
CL2010001486A1 (es) Compuestos derivados de [1,2,4]triazolo[1,5-a]piridina, inhibidores de jak; composicion farmaceutica; kit farmaceutico; su uso en el tratamiento de enfermedades tales como cancer, diabetes, enfermedad de alzheimer, enfermedad hepatica, trastornos del snc, entre otras.
PE20120629A1 (es) Compuesto triazolopiridina y su accion como inhibidor de prolil hidroxilasa e inductor de la produccion de eritropoyetina
AR040773A1 (es) Pirazoles utiles como inhibidores de gsk-3
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
TW200616634A (en) Crystalline forms and process for preparing spiro-hydantoin compounds
AR052871A1 (es) Una sintesis exo-selectiva de analogos de himbacina
EA200601845A1 (ru) НОВЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ
AR042002A1 (es) Benzoxazinonas sustituidas, proceso de obtencion y usos para tratamiento de enfermedades del sistema nervioso central.
HUP0001396A2 (hu) 3-Amino-3 aril-propán-1-ol-származékok, előállításuk és felhasználásuk
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
NI200700235A (es) Procesos y métodos para la preparación de cis-2- hidroximetil-4-citosin-1'-yl)-1,3- oxatiolane ópticamente activo o sales farmacéuticamente aceptables de los mismos
RU2007144740A (ru) Фотосенсибилизатор и способы его получения
Ranganathan The total synthesis of chlorophyll
JP2013543841A5 (es)
AR117133A1 (es) Heterociclos funcionalizados como agentes antivirales
ES2381813T9 (es) Procedimiento para la preparación de ésteres del ácido 2,3,4,9-tetrahidro-1H-beta-carbolin-3-carboxílico
CN110078726B (zh) 一种全取代2,3-二氢-1H-吡咯并[2,3-b]吡啶衍生物的合成方法
AR070492A1 (es) Derivados de 4- aminociclohexano sustituido

Legal Events

Date Code Title Description
FB Suspension of granting procedure
FA Abandonment or withdrawal
FA Abandonment or withdrawal